Please login to the form below

Not currently logged in
Email:
Password:

anti-inflammatory

This page shows the latest anti-inflammatory news and features for those working in and with pharma, biotech and healthcare.

Trial data suggest Abivax’ drug may clear latent HIV

Trial data suggest Abivax’ drug may clear latent HIV

The Goetz analyst says that ABX464’s double whammy of antiviral and anti-inflammatory effects could be another plus for the drug, as inflammation is “a significant problem in HIV ... Those anti-inflammatory properties have encouraged Abivax to carry

Latest news

More from news
Approximately 1 fully matching, plus 130 partially matching documents found.

Latest Intelligence

  • Deal Watch October 2015 Deal Watch October 2015

    Under the agreement Janssen has an option to license enGene's lead candidate, EG-12, for the gut-localised expression of the anti-inflammatory cytokine IL-10 in indications such as ... Up to 3 anti-PD-1 based bispecific antibodies for oncology. Expansion

  • Pharma deals during December 2014 Pharma deals during December 2014

    J&J has been busy entering into licences and research collaborations on the one hand, while exercising an opt-out and terminating its $945m anti-inflammatory deal with Astellas that was ... In early December, Merck added more weight to its

  • Investing in the future of R&D Investing in the future of R&D

    The anti-inflammatory TNF drug, whose indications currently include rheumatoid arthritis and Crohn's disease, became UCB's leading product in the first half of 2014, thanks to 23% growth in ... This was followed in March by a drug discovery and

  • Back to the future Back to the future

    The best-selling biologic - and still pharma's biggest global brand - is Humira, AbbVie and Eisai's anti-inflammatory drug.

  • Deal Watch table for March 2014 Deal Watch table for March 2014

    167. UCB/ Sanofi. Collaboration - discovery/ development. Anti-inflammatory small molecules for treatment of immune-mediated disorders (discovery). ... 23. Genmab/ Janssen. Milestone payment. Daratumumab, anti-CD38 mAb for multiple myeloma (p2 milestone).

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics